Farms.com Home   News

Agronomic Conservations to Address Supply Chain Disruptions

Given current global challenges, lawmakers have proposed allowing select land currently enrolled or soon-to-be enrolled in the Conservation Reserve Program (CRP) to be opened for crop production in the immediate future. In 2021, approximately 315,000 U.S. producers received CRP payments, accounting for roughly 22 million acres enrolled in the CRP program or 8.7% of U.S. cropland.

ASA, CSSA, and SSSA members and certified professionals drafted scientific and agronomic considerations that address a potential shift in land use out of conservation and into crop production. We recognize that these are not the only points to be considered and acknowledge the growing global food security challenges brought on by Russia’s invasion in Ukraine.

The following are the key takeaways from the report:

  • In most cases, converting CRP acres to crop production is resource intensive and may require more time and agronomic inputs than currently available prior to the 2022 growing season. Conversion may be more feasible for the 2022 winter growing season or 2023 spring growing season.
  • Crop yields tend to be below average the first year after CRP is converted to cropland. Combined with high input prices and low supply, producers may face economic challenges upon converting CRP to cropland at this time even though crop prices are also high.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.